Effects of narcotic antagonists on L-dopa reversal of reserpine-induced catalepsy and blepharoptosis in mice.
D000818:Animals; D001763:Blepharoptosis / Q000139:chemically induced / Q000503:physiopathology*; D002375:Catalepsy / Q000139:chemically induced / Q000503:physiopathology*; D004336:Drug Antagonism; D004357:Drug Synergism; D006801:Humans; D007700:Kinetics; D007980:Levodopa / Q000494:pharmacology*; D008297:Male; D051379:Mice; D009270:Naloxone / Q000031:analogs & derivatives* / Q000494:pharmacology*; D009271:Naltrexone / Q000494:pharmacology*; D012110:Reserpine / Q000494:pharmacology*
D009270:Naloxone; D007980:Levodopa; D009271:Naltrexone; D012110:Reserpine